Studies have shown that prostate cancer cells transfer pyruvate kinase M2 (PKM2) to bone marrow stromal cells (BMSCs) through exosomes, upregulating CXCL12 production to “educate” the bone marrow microenvironment and create pre-metastatic niches. Here, CXCL12 is linked to Familial prostate cancer.